Unique ID issued by UMIN | UMIN000041240 |
---|---|
Receipt number | R000047097 |
Scientific Title | The efficacy and safety of transurethral enucleation of the prostate for benign prostatic hyperplasia using King health questionnaire assessment |
Date of disclosure of the study information | 2020/07/29 |
Last modified on | 2022/07/31 15:26:50 |
The efficacy and safety of transurethral enucleation of the prostate for benign prostatic hyperplasia using King health questionnaire assessment
The efficacy and safety of HoLEP using King health questionnaire assessment
The efficacy and safety of transurethral enucleation of the prostate for benign prostatic hyperplasia using King health questionnaire assessment
The efficacy and safety of HoLEP using King health questionnaire assessment
Japan |
benign prostatic hyperplasia
Urology |
Others
NO
To examine the efficacy and safety of transurethral enucleation of the prostate (HoLEP) for benign prostatic hyperplasia using the King Health Questionnaire.
Efficacy
Quality of life assessment using the King Health Study at 1, 3 and 6 months post-operatively
Observational
50 | years-old | <= |
90 | years-old | > |
Male
1)Estimated prostate volume is 30 ml or more
2)Patients who will undergo Holmium laser enucleation of the prostate at our hospital
1)Patients who have severe incontinence before surgery due to severe cerebrovascular disorder or spinal cord injury
100
1st name | Go |
Middle name | |
Last name | Anan |
Tohoku Medical and Pharmaceutical University Hospital
Department of Urology
983-8536
1-15-1 Fukumuro, Miyagino-ku, Sendai, Miyagi
022-234-4181
goanan@tohoku-mpu.ac.jp
1st name | Go |
Middle name | |
Last name | Anan |
Tohoku Medical and Pharmaceutical University Hospital
Department of Urology
N/A
1-15-1 Fukumuro, Miyagino-ku, Sendai, Miyagi
022-234-4181
goanan@tohoku-mpu.ac.jp
Tohoku Medical and Pharmaceutical University
Tohoku Medical and Pharmaceutical University
Other
Tohoku Medical and Pharmaceutical University
1-15-1 Fukumuro, Miyagino-ku, Sendai, Miyagi
022-259-1221
tikenn@hosp.tohoku-mpu.ac.jp
NO
2020 | Year | 07 | Month | 29 | Day |
https://www.hosp.tohoku-mpu.ac.jp/center/cr_support_center/disclosure.html
Unpublished
none
100
HoLEP could be safe and effective even for men aged more than 75 years, comparing complications, urinary condition, and KHQ scores.
2022 | Year | 07 | Month | 31 | Day |
1)Estimated prostate volume is 30 ml or more
2)Patients who will undergo Holmium laser enucleation of the prostate at our hospital
Patients undergoing HOLEP surgery were asked to complete a preoperative and postoperative questionnaire and gave their consent.
non
Quality of life assessment using the King Health Study at 1, 3 and 6 months post-operatively
Completed
2017 | Year | 07 | Month | 21 | Day |
2017 | Year | 07 | Month | 21 | Day |
2017 | Year | 07 | Month | 21 | Day |
2021 | Year | 03 | Month | 31 | Day |
Quality of life assessment using the King Health Survey before and after surgery
2020 | Year | 07 | Month | 29 | Day |
2022 | Year | 07 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047097
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |